Dear Editor,The early diagnosis and prognosis of COVID-19 remain major challenges.At present,there are few studies focusing on the changes of sera proteome betAA/een active and recovered COVID-19 patients,and almost n...Dear Editor,The early diagnosis and prognosis of COVID-19 remain major challenges.At present,there are few studies focusing on the changes of sera proteome betAA/een active and recovered COVID-19 patients,and almost no biomarkers in sera are used to predict the function disorder of the injured tissues and organs in COVID-19 patients.In this study,we applied sera proteomics in the active and recovered COVID-19 patients,as well as healthy volunteers,combining with pathological staining of the patients'tissues to identify the potential prognosis biomarkers that can reflect specific organ damage.展开更多
基金This work was supported by the National Science and Technology Major Project(2018ZX09711003)the CAMS Innovation Fund for Medical Sciences(CIFMS)(2020-I2M-CoV19-001).
文摘Dear Editor,The early diagnosis and prognosis of COVID-19 remain major challenges.At present,there are few studies focusing on the changes of sera proteome betAA/een active and recovered COVID-19 patients,and almost no biomarkers in sera are used to predict the function disorder of the injured tissues and organs in COVID-19 patients.In this study,we applied sera proteomics in the active and recovered COVID-19 patients,as well as healthy volunteers,combining with pathological staining of the patients'tissues to identify the potential prognosis biomarkers that can reflect specific organ damage.
